Loading…

Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200

Saved in:

Bibliographic Details
Published in:	Blood 2003-01, Vol.101 (2), p.779-780
Main Authors:	Ho, Aloysius Y.L., Kenyon, Michelle, El-Hemaidi, Ihab, Devereux, Stephen, Pagliuca, Antonio, Mufti, Ghulam J.
Format:	Article
Language:	English
Subjects:	Adolescent Adult Aged Alemtuzumab Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Antibodies, Neoplasm - administration & dosage Hematologic Diseases - complications Hematologic Diseases - mortality Hematologic Diseases - therapy Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods Hematopoietic Stem Cell Transplantation - mortality Humans Middle Aged Survival Analysis Transplantation Conditioning - adverse effects Transplantation Conditioning - methods Transplantation Conditioning - mortality Transplantation, Homologous - adverse effects Transplantation, Homologous - methods Transplantation, Homologous - mortality Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!